文献速递神经肿瘤

垂体腺瘤诊疗量与治疗模式及短期手术结局的关联:NCDB分析

Association between facility volume with treatment patterns and short-term surgical outcomes in pituitary adenoma: a National Cancer Database analysis.
PubMed 文献 · J Neurosurg · 2025-08-29

基于美国国家癌症数据库2010–2021年100,471例成人垂体腺瘤患者、1227家医院数据,按年均诊疗量四分位分组。高流量医院(Q4)患者更可能接受手术和药物治疗、较少放疗,术后延长住院和30/90天死亡风险更低,但30天非计划再入院无差异。

要点

  • 高流量医院垂体腺瘤患者接受手术的OR为2.08(95%CI 1.97-2.20)。
  • Q4医院内镜手术占70.8%,Q1医院为45.0%。
  • Q4医院术后延长住院、30天和90天死亡风险均更低。

核心结论

  • 在高流量机构治疗与更高的手术概率、更低的术后延长住院和围手术期死亡风险相关。

研究设计与样本

  • 回顾性队列研究,查询NCDB中2010–2021年诊断为垂体腺瘤的成人患者,按医院年均诊疗量四分位分组。
  • 共纳入100,471例患者,分布于1227家医院;Q1为≤8.73例/年,Q2为8.74–20.60,Q3为20.61–48.40,Q4为≥48.41。
  • 采用多变量logistic回归评估治疗模式和短期手术结局,调整患者社会人口学和临床特征。

主要发现

  • 79.1%的医院属于Q1,仅28家(2.3%)属于Q4。
  • 与Q1相比,Q4患者更可能接受手术(OR 2.08,95%CI 1.97-2.20)和药物治疗(OR 2.40,95%CI 2.24-2.57),均p<0.001。
  • Q4医院内镜手术比例为70.8%,Q1医院为45.0%。
  • 与Q1相比,Q4患者接受放疗的OR为0.68(95%CI 0.58-0.80;p<0.001)。
  • Q4较Q1的术后延长住院OR为0.54(95%CI 0.49-0.59)、30天死亡OR为0.42(95%CI 0.27-0.65)、90天死亡OR为0.52(95%CI 0.37-0.73),均p<0.001。

临床怎么用

  • 对复杂垂体腺瘤病例,可优先考虑集中至高流量、多学科团队机构进行综合管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pituitary adenomas (PAs) are common intracranial neoplasms for which definitive treatment is generally transsphenoidal resection depending on patient and tumor characteristics. Recent studies have demonstrated that patients with other intracranial tumors treated at high-volume centers are more likely to undergo surgery, receive adjuvant therapy, and experience improved surgical outcomes. However, PAs have yet to be studied in this context. The authors investigated the association between facility volume with treatment patterns and short-term surgical outcomes in patients with PA using data from the National Cancer Database (NCDB). METHODS: The NCDB was queried for adult patients diagnosed with PA between 2010 and 2021. Facility volume was categorized into quartiles based on the average number of patients managed per year: quartile 1 (Q1, ≤ 8.73), quartile 2 (Q2, 8.74-20.60), quartile 3 (Q3, 20.61-48.40), and quartile 4 (Q4, ≥ 48.41). Multivariable logistic regression models were constructed to assess treatment patterns and short-term surgical outcomes (extended length of stay [> 4 days], unplanned 30-day readmission, 30-day mortality, and 90-day mortality), adjusting for patient sociodemographic and clinical characteristics. RESULTS: A total of 100,471 patients treated at 1227 hospitals were included. The majority of hospitals were in Q1 (79.1%), while 28 hospitals (2.3%) qualified for Q4. Patients at Q4 hospitals were more likely to undergo surgery (OR 2.08, 95% CI 1.97-2.20) and receive medical therapy (OR 2.40, 95% CI 2.24-2.57) compared with patients at Q1 hospitals (both p < 0.001). Endoscopic surgery was more frequently performed at Q4 hospitals (70.8%) than Q1 hospitals (45.0%). Compared with patients at Q1 hospitals, patients at Q4 hospitals demonstrated lower odds of receiving radiotherapy (OR 0.68, 95% CI 0.58-0.80; p < 0.001). Patients treated at Q4 hospitals exhibited a lower likelihood of extended postsurgical length of stay (OR 0.54, 95% CI 0.49-0.59), 30-day mortality (OR 0.42, 95% CI 0.27-0.65), and 90-day mortality (OR 0.52, 95% CI 0.37-0.73) in comparison with patients at Q1 hospitals (all p < 0.001). However, no significant difference in unplanned readmission within 30 days of surgery (OR 0.95, 95% CI 0.79-1.15; p = 0.615) was observed between Q4 and Q1 hospitals. CONCLUSIONS: Treatment at higher-volume facilities is associated with higher odds of undergoing surgery, along with significantly lower odds of extended postsurgical length of stay and perioperative mortality. These findings highlight the importance of centralized care at high-volume institutions, where multidisciplinary teams can offer comprehensive management for complex cases.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Pham J, Gomez D, Shah I, et al. Association between facility volume with treatment patterns and short-term surgical outcomes in pituitary adenoma: a National Cancer Database analysis. J Neurosurg. 2025. PMID: 40882234. doi:10.3171/2025.4.JNS25716

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。